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Brain abscesses can cause an incapacitating neurological deicit in up to 50% of patients, thus 
the reduction of these sequelae becomes the main goal of its timely and speciic surgical and 
medical treatment. With technological advances in bacteriological identiication and diagnostic 
imaging, the clinical suspicion can be conirmed, and the speciic etiological agent can be iden-
tiied in a larger number of cases. New pathogens have emerged through this process, such as 
Streptococcus porcinus, in which the ability to affect the central nervous system has not been 
documented.
A clinical case is presented of a brain abscess in an immunocompetent patient, and its favorable 
response to surgical drainage through a skull burr hole and needle aspiration with antibiotic 
therapy (ceftriaxone, metronidazole and vancomycin) is discussed.
© 2014 Revista Medicina Universitaria. Facultad de Medicina UANL. Published by Elsevier México. All rights 
reserved. 
Introduction
Brain abscesses are supurative, focal intracranial infections, 
which start as a localized area of cerebritis in the paren-
chyma, and become collections of purulent material 
wrapped inside a highly vascularized capsule.1 Its incidence 
in the United States is between 1500 and 2000 cases a year. 
It is estimated to be a higher number in developing coun-
tries.2 The causes may vary depending on the patient’s so-
cioeconomic conditions and his/her location, for instance, 
in underdeveloped countries otogenic infections are the 
most common; additionally, in 25% to 38% of the cases the 
source is unknown, thus classifying it as “cryptogenic”. Signs 
and symptoms are not speciic for this pathology; patients 
develop headaches and fevers, and show decreased con-
sciousness, nausea and/or vomiting as well as seizures. A 
key point for patient treatment is the pathogen identiica-
tion through a culture of the obtained material after per-
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forming surgical drainage of the abscess. Isolated 
microorganisms are frequently Streptococcus and Staphylo-
coccus strains, however, it is common to ind multiple or-
ganisms. Nevertheless the range of negative results in 
cerebral abscess cultures may be up to 34%.2
An emerging infectious disease (EID) is an infectious dis-
ease whose incidence has increased in the past 35 years and 
is projected to increase in the future.3 EIDs are caused by 
identiied infectious species or strains that may be part of 
an already known infection (i.e. Inluenza) or that is dis-
seminating in a new population. Below, we present an 
emerging pathogen, which until now hadn’t occurred in the 
central nervous system, as well as the patient’s surgical 
treatment and evolution. 
Case presentation
The patient was a 38-year-old male, construction worker, 
from a rural community —lacking drinking water and a sew-
age system— called Galeana, in Nuevo León, Mexico, with a 
low socio-economic level, occasional alcoholism, with a his-
tory of second-degree electrical burns on face and both 
hands seven months prior to his hospital admission. His 
symptoms began with a holocranial headache of moderate 
intensity and left upper limb monoparesis; due to this he 
went for a consultation at a irst-level hospital in his com-
munity, where he was referred to a second-level hospital 
and a cranial CT scan were performed. Next he was referred 
to our hospital’s Emergency Department where he was as-
sessed 48 h after the onset of symptoms, the intensity of his 
headache having increased and adding an altered state of 
consciousness. During physical and neurological examina-
tion the patient scored 14 points on the Glasgow coma 
scale. He was somnolent, with isocoric pupils at 3 mm and a 
normal response to luminous stimulus. He also suffered 
from left VII cranial nerve supranuclear palsy, uneven left-
sided hemiparesis 4/5 superior on the Lovett scale and infe-
rior Barre sign, left pyramidal syndrome. His sensitive and 
vestibular-cerebellar systems were unaltered.
On cranial CT scan, we were able to observe a right pari-
etal heterogeneous lesion in the motor cortex with an ap-
proximate volume of 5 mL with a perilesional vasogenic 
edema, involving folds and grooves, with a respected mid-
line and ventricular system and a basal cistern without al-
terations, bone lesions or fractures. 
On brain MRI, we were able to observe a hyperintense le-
sion in the right parietal on T2, isointense on T1, with a 
perilesional edema without restricted diffusion. In the gad-
olinium contrast-enhanced sequence, we were able to see 
the characteristic “ring-shaped” lesion (igure 1).
Under the diagnostic suspicion for cerebral abscess, med-
ical surgical treatment consisted of draining the abscess 
through a small transcortical incision via a temporal skull 
burr hole (22 mm diameter) and needle aspiration. After we 
performed the procedure, we obtained 20 mL of dark green 
purulent luid. We reported the immediate Gram stain with 
positive cocci Gram stain, abundant polymorphonuclears 
and scarce limphocytes (igure 2). The inal culture report 
isolated S. porcinus; the antibiogram was not performed be-
cause the bacteria perished.
The patient’s postoperative evolution was satisfactory, 
left fascio-corporal weakness remained with the same char-
acteristics and pyramidal syndrome. We began antibiotic 
therapy with 2 g of ceftriaxone every 12 h, 1 g of vancomy-
cin every 12 h, and 500 mg of metronidazole every 8 h, also 
8 mg of dexamethasone every 8 h and 100 mg of phenytoin 
every 8 h. All medications were administered intravenously.
We performed a cranial CT scan with contrast 10 days af-
ter surgery, where we were able to see an abscess recur-
rence and an increment in size to 15 mL (figure 3). The 
patient remained in the same clinical condition during that 
period of time. We decided to perform a second surgery 
Figure 1 Gadolinium contrast-enhanced sequence magnetic 
resonance imaging, with an intracerebral lesion on the right 
parietal lobe which shows the “ring shape”.
Figure 2 Puncture and drainage of the abscess by temporal 
skull burr hole showing purulent liquid.
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consisting of a right parietal burr hole (22 mm) and reopen-
ing of the initial right temporal burr hole for abscess needle 
aspiration, obtaining 15 mL of yellowish green purulent luid 
from the parietal burr hole and 12 mL of hematic fluid 
mixed with dark green purulent fluid from the temporal 
skull burr hole.
The patient continued with the same antibiotic scheme 
for 15 days then we stopped vancomycin as indicated by the 
Infectious Diseases Service, continuing the ceftriaxone and 
metronidazole scheme at the same dosage for 8 weeks. We 
performed a brain CT scan with contrast and we observed 
cerebral abscess resolution with a minor residual vasogenic 
edema in the surgical area (igure 4). The patient was dis-
charged alert and conscious without superior mental func-
tion alterations, isocoric and normoreactive pupils, left VII 
cranial nerve supranuclear palsy, and left upper limb mono-
paresis characterized by a Mingazzini sign, left hemibody 
hyperrelexia, hemodynamically stable, afebrile and toler-
ating an oral diet. 
Discussion
Emerging and re-emerging diseases have been the focal 
point during the last decade because of technological ad-
vances to make a diagnosis, either in the ield of imaging 
studies or in new laboratory and bacteriological techniques, 
all this in order to increase our ability to identify the patho-
gens causing the diseases in a timely manner, and imple-
ment appropriate therapies and preventative measures to 
impede the spread of a condition or disease to dimensions 
that go from an epidemic outbreak to a pandemic.
S. porcinus is a Streptococcus beta-hemolytic of the 
Lanceield groups E, P, V, U, NG1 (A1, C1), NG2 and NG3, 
irst isolated from a pig in 1937 and formally described in 
1984.4 The pig has been established as its main reservoir, 
however it has been isolated from other animals such as 
sheep, rabbits, dogs and cows, colonizing the upper airway 
and the genitourinary tract, causing supurative infections 
like lymphadenitis, pneumonia, cellulitis and septicemia. It 
has also been related to endocarditis and miscarriages.5,6
Isolation documentation of S. porcinus in human sources 
is rare and has been linked mainly to genitourinary tract in-
fections in women who are at a reproductive age. Since 
1960 there have been 32 reported cases in humans; 22 in 
women, 3 in men and 7 in which gender was not document-
ed, 18 being isolated in the genitourinary tract (amniotic 
luid, placenta, cervix, vagina or urine), 6 from wounds, 3 in 
blood and 1 from the navel, leaving 4 in which no isolation 
place was reported.5,7 Related infections to this pathogen 
included chorioamnionitis or postpartum endometritis, cel-
lulitis and septicemia. However, the transmission mecha-
nism of this bacteria is not clear, and up to this moment it is 
believed to colonize the genitourinary tract due to altera-
tions in the vaginal lora and by contact, because in two of 
the isolations in wounds it was in people who were in con-
tact with pork at the workplace. 
We reported the irst clinical case in our institution of a 
brain abscess (in which S. porcinus was isolated) in an im-
munocompetent patient. Because we didn’t have speciic 
scientiic documentation about the infection in the central 
nervous system by this agent, we followed the basic princi-
ples of cerebral abscess treatment when this met surgical 
criteria8, deciding to perform a surgical drainage through a 
skull burr hole of the lesion and not a craniotomy (the pa-
Figure 4 Contrasted computerized tomography scan with ab-
scess drainage, empty capsule shown.
Figure 3 Contrasted coronal computerized tomography scan 
with bilobed recurrent abscess. 
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tient’s clinic’s irst choice) due to the experience in our ser-
vice and the opinion of the Infectious Diseases Service, who 
indicated effective antibiotics against this pathogen, taking 
into account its bacteriological group, because a mortality 
rate of 10% and disabling neurological deicits in up to 45% 
of patients has been established.9
Cerebral intraparenchymal abscesses are a common enti-
ty in neurosurgical practices. Nevertheless, the pathogen 
spectrum that may cause infection in the central nervous 
system is wide and has expanded through the years for dif-
ferent reasons such as HIV infections and patients who un-
dergo organ transplants which require pharmacological 
immunosuppression for prolonged periods of time. Another 
important aspect is the evolution of bacteriological identii-
cation techniques which have also made more eficient and 
expedited treatments in immunocompetent as well as im-
munosuppressed patients possible; this is of great help to 
continue reducing morbidity associated with this condition.
In conclusion, the treatment was effective in accomplish-
ing the healing of a patient infected by an uncommon 
pathogen. It is important to highlight the fact that as far as 
we were concerned, there hadn’t been a report of its isola-
tion in brain tissue. On the other hand, we must encourage 
the sharing of this information, because there is the poten-
tial risk of a new strain of microorganisms that may appear 
as an emerging disease and cause outbreaks, or even pan-
demics.
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